Healthcare -
Biotechnology - NASDAQ - US
$ 3.715
5.84 %
$ 318 M
Market Cap
-0.97
P/E
AMLX - OPERATING INCOME
Operating Income AMLX - Amylyx Pharmaceuticals, Inc.
38.8 M
LAST VALUE
57.14%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR